Effect of short-term pre-operative tamoxifen on the cytological grade of breast cancer

Breast

Volumn 5, Issue 2, 1996, Pages 89-91

  Robinson, I A ^a   McKee, G ^a   Rendell, L ^a   Sayer, B ^a   Kissin, M W ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; CANCER GRADING; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORPHOLOGY; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0029936626     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(96)90127-7     Document Type: Article

References (22)

1. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992; i: 1-15.
2. Love R, Koroltchouk V. Tamoxifen therapy in breast cancer control worldwide. Bull World Health Organ 1993; 71: 795-803.
3. Plowman P. Tamoxifen as adjuvant therapy in breast cancer. Current status. Drugs 1993; 46: 819-33.
4. Taylor C, Georgian-Smith D. Regression of breast cancer in four patients treated with tamoxifen: mammographic features. AJR Am J Roentgenol 1994; 162: 613-616.
5. Bates T, Riley D, Houghton J, Baum M. Tamoxifen treatment of breast cancer in elderly patients. Br J Surg 1992; 79: 454-459.
6. Ciatto S, Bartoli D, Iossa A, Grazzini G, Cirillo A. Response of primary breast cancer to tamoxifen alone in elderly women. Tumori 1991; 77: 328-330.
7. Haybittle J, Blamey R, Elston C et al. A prognostic index in primary breast cancer. Br J Cancer 1982; 45: 361-366.
8. Elston C, Ellis I. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
9. Todd J, Dowle C, Williams M et al. Confirmation of a prognostic index in primary breast cancer. Br J Cancer 1987; 56: 489-492.
10. Morgan D, Sibbering D, Galea M, Ellis I, Elston C, Blarney R. Selection for adjuvant therapy using the Nottingham Prognostic Index. Breast 1993; 2: 206.
11. Robinson I, McKee G, Nicholson A et al. Prognostic value of fine-needle aspirates from breast carcinomas. Lancet 1994; i: 947-949.
12. National Institute of Health Consensus Development Statement on the Treatment of Early Stage Breast Cancer. Oncology 1991; 5: 120-124.
13. Gazet J, Markopopoulos C, Ford H, Coombes R, Bland J, Dixon R. Prospective randomised trial of tamoxifen verses surgery in the elderly patient. Lancet 1988; i: 679-681.
14. Robertson J, Todd J, Ellis I, Elston C, Blarney R. Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer. BMJ 1988; 297: 511-514.
15. Clarke R, Laidlaw I, Jones L, Howell A, Anderson E. Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status. Br J Cancer 1993; 67: 606-611.
16. du Toit R, Locker A, Ellis I et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol 1991; 17: 251-257.
17. Wilson Y, Rhodes M, Ibrahim N, Padfield C, Cawthorn S. Immunocytochemical staining of PS2 protein in fine needle aspirate from breast cancer is an accurate guide to response to tamoxifen in patients over 70 years. Br J Surg 1994; 81: 1155-1158.
18. Frierson H, Fechner R. Histological grade of locally advanced infiltrating ductal carcinoma after treatment with induction chemotherapy. Am J Clin Path 1994; 102: 154-157.
19. Kennedy S, Merino M, Swain S, Lippman M. The effect of hormonal and chemotherapy on tumoral and non-neoplastic breast tissue. Human Pathology 1990; 21: 192-198.
20. Rasbridge S, Gillett C, Seymore A et al. The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma. Br J Cancer 1994; 70: 335-341.
21. Forouhi P, Walsh J, Anderson T, Chetty U. Ultrasound as a method of measuring breast tumour size and monitoring response to primary systemic treatment. Br J Surg 1994; 81: 223-225.
22. Paine J, Ebbs S, Hearne R, Lowe S, Bradbeer J. Assessment of breast cancer size: a comparison of methods. Eur J Surg Oncol 1992; 18: 44-48.